Evoke Pharma Presents Additional GIMOTI Healthcare Utilization Data Focused On Gastroparesis Care Insights In Women At DDW 2024 Conference
Portfolio Pulse from Benzinga Newsdesk
Evoke Pharma, Inc. (NASDAQ:EVOK) will present data on GIMOTI® nasal spray for gastroparesis care in women at the 2024 Digestive Disease Week Conference.
May 16, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evoke Pharma will present data on GIMOTI® nasal spray for gastroparesis care in women at the 2024 Digestive Disease Week Conference, potentially increasing visibility and interest in their product.
Presenting at a major conference like DDW 2024 can increase visibility and credibility for Evoke Pharma's GIMOTI® nasal spray, potentially leading to higher interest and adoption in the healthcare community.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100